Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study

Summary

The purpose of this study is to determine if the medication, sildenafil (also known as Revatio), can slow or stop the progression of liver disease in patients who previously had a Fontan operation.

Timeline

Start

2017-07-05

Primary completion

2019-06-30

Completion

2019-06-30

Drugs

Indications